-

Securities Fraud Class Action Lawsuit Pending Against D-Wave Quantum, Inc.: The Law Offices of Howard G. Smith Highlights Lead Plaintiff Deadline

Suit alleges D-Wave Quantum, Inc. failed to disclose material facts to investors who bought from February 26, 2026 through August 25, 2026; investors may seek lead plaintiff appointment by December 15, 2026

BENSALEM, Pa.--(BUSINESS WIRE)--D-Wave Quantum, Inc. ("D-Wave" or the "Company") (NASDAQ: QBTS) is the subject of a securities fraud class action lawsuit filed on behalf of investors who purchased or otherwise acquired the Company's securities from February 26, 2026 through August 25, 2026, inclusive. The Law Offices of Howard G. Smith today reported the lawsuit, Fessler v. D-Wave Quantum, Inc. et al., which was filed on October 15, 2026 in the U.S. District Court California Northern District (Case No. 3:26-cv-11953). The deadline for D-Wave Quantum, Inc. investors to file a lead plaintiff motion is December 15, 2026.

Investors with losses on D-Wave Quantum, Inc. securities can contact The Law Offices of Howard G. Smith about the D-Wave Quantum, Inc. class action to discuss potential claims under the federal securities laws before the December 15, 2026 lead plaintiff deadline.

Important dates in the D-Wave Quantum, Inc. case

  • Complaint filing date: October 15, 2026
  • Court: U.S. District Court California Northern District
  • Class period: February 26, 2026 through August 25, 2026, inclusive
  • Deadline for lead plaintiff motions: December 15, 2026

What happened?

On August 6, 2026, D-Wave reported its second quarter of 2026 financial results. Among other things, D-Wave issues revenue of only $3.08 million, compared to $3.1 million for the same period in 2025.

On this news, D-Wave's stock price fell $1.98 per share, or 9.28%, to close at $19.41 per share on August 6, 2026, thereby injuring investors.

Then, on August 25, 2026, D-Wave issued a press release “announc[ing] that John Markovich is retiring and thus resigning from his position as Chief Financial Officer effective September 2, 2026.”

On this news, D-Waves stock price fell $1.84 per share, or 9.51%, to close at $17.51 per share on August 26, 2026, thereby further injuring investors.

Allegations in the D-Wave Quantum, Inc. lawsuit

The D-Wave Quantum, Inc. shareholder lawsuit alleges that, throughout the class period, defendants made materially false and/or misleading statements and failed to disclose material adverse facts about D-Wave Quantum, Inc.'s business, operations, and prospects. Specifically, the complaint alleges defendants failed to disclose to investors that: (1) Defendants materially overstated D-Wave’s business and financial prospects; (2) the foregoing was reasonably likely to negatively impact the Company’s business and reputation; and (3) as a result, defendants' positive statements about D-Wave Quantum, Inc.'s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

D-Wave Quantum, Inc. investors who purchased or otherwise acquired securities during the class period may move the Court by December 15, 2026 to seek appointment as lead plaintiff in this putative class action.

"The lawsuit against D-Wave Quantum, Inc. alleges that, among other things, the Company failed to tell investors that Defendants materially overstated D-Wave’s business and financial prospects. D-Wave Quantum, Inc. investors who bought during the class period may be able to pursue their losses through this class action, and the December 15, 2026 lead plaintiff deadline is an important first date," said Howard G. Smith of The Law Offices of Howard G. Smith.

Next steps for D-Wave Quantum, Inc. investors

D-Wave Quantum, Inc. investors who suffered losses may contact The Law Offices of Howard G. Smith to learn about pursuing their claims. For more information, visit the firm's website, email howardsmith@howardsmithlaw.com, or call (215) 638-4847.

To be a member of the D-Wave Quantum, Inc. class, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent class member. No class has been certified so far in the D-Wave Quantum, Inc. case.

Common questions from D-Wave Quantum, Inc. investors

Who is eligible? Investors who acquired D-Wave Quantum, Inc. securities from February 26, 2026 through August 25, 2026 and suffered losses may qualify for the class in the D-Wave Quantum, Inc. shareholder lawsuit.

Where is the D-Wave Quantum, Inc. case pending? The D-Wave Quantum, Inc. class action, Fessler v. D-Wave Quantum, Inc. et al., is pending in the U.S. District Court California Northern District (Case No. 3:26-cv-11953).

Do I have to do anything to be in the D-Wave Quantum, Inc. class? No, D-Wave Quantum, Inc. investors need not take any action at this time and may remain absent class members.

Does it cost anything? The Law Offices of Howard G. Smith works on contingency, meaning D-Wave Quantum, Inc. investors owe no attorneys' fees out of pocket. Any attorneys' fees and litigation expenses are paid solely from a recovery, if achieved, and require court approval.

About The Law Offices of Howard G. Smith

The Law Offices of Howard G. Smith has helped injured investors recover their money for more than 15 years. The firm prosecutes securities fraud, takeover, and derivative litigation against public companies and their officers, directors, and advisors in federal and state courts nationwide, and has helped clients recover hundreds of millions of dollars in losses. Clients speak directly with a lawyer, who will promptly answer any question.

Prior results do not guarantee a similar outcome.

Related links

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Howard G. Smith
The Law Offices of Howard G. Smith
3070 Bristol Pike, Suite 112
Bensalem, PA 19020
Email: howardsmith@howardsmithlaw.com
Telephone: (215) 638-4847
www.howardsmithlaw.com

The Law Offices of Howard G. Smith

NASDAQ:QBTS

Release Versions

Contacts

Howard G. Smith
The Law Offices of Howard G. Smith
3070 Bristol Pike, Suite 112
Bensalem, PA 19020
Email: howardsmith@howardsmithlaw.com
Telephone: (215) 638-4847
www.howardsmithlaw.com

More News From The Law Offices of Howard G. Smith

Deadline Alert: Millrose Properties, Inc. Stockholders Face December 8, 2026 Lead Plaintiff Deadline in Securities Fraud Class Action, The Law Offices of Howard G. Smith Highlights

BENSALEM, Pa.--(BUSINESS WIRE)--Millrose Properties, Inc. ("Millrose" or the "Company") (NYSE: MRP) investors who wish to serve as lead plaintiff in a pending securities fraud class action lawsuit must move the Court by December 8, 2026. The suit was filed on behalf of investors who purchased or otherwise acquired the Company's securities from February 7, 2025 through October 2, 2026, inclusive. The Law Offices of Howard G. Smith today highlighted the deadline in the case, Rubenstsein et al. v....

Deadline Alert: The Chemours Company Stockholders Face December 7, 2026 Lead Plaintiff Deadline in Securities Fraud Class Action, The Law Offices of Howard G. Smith Highlights

BENSALEM, Pa.--(BUSINESS WIRE)--The Chemours Company ("Chemours" or the "Company") (NYSE: CC) investors who wish to serve as lead plaintiff in a pending securities fraud class action lawsuit must move the Court by December 7, 2026. The suit was filed on behalf of investors who purchased or otherwise acquired the Company's securities from February 20, 2026 through August 4, 2026, inclusive. The Law Offices of Howard G. Smith today highlighted the deadline in the case, Darcy v. The Chemours Compan...

Did You Lose Money on Integra LifeSciences Holdings Corporation Stock? The Law Offices of Howard G. Smith Announces Securities Fraud Investigation After 21.2% Share Price Decline

BENSALEM, Pa.--(BUSINESS WIRE)--Investors who suffered losses on Integra LifeSciences Holdings Corporation ("Integra" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today reported that it is conducting a securities fraud investigation on behalf of Integra LifeSciences Holdings Corporation (NASDAQ: IART) investors into whether the Company may have violated the federal securities laws. The investigation comes after a October 2, 2026 disclosure c...
Back to Newsroom